Brief: BOD Australia Enters Agreement With Australia's Respiratory And Sleep Institute

Bod Science

22/09/2021 24:47

Sept 22 (Reuters) - BOD Australia Ltd  BDA.AX :
    * ENTERS AGREEMENT WITH AUSTRALIA'S RESPIRATORY AND SLEEP
INSTITUTE FOR A SCHEDULE 3 CLINICAL TRIAL OF A NEW CBD PRODUCT
    * STUDY WILL INVESTIGATE EFFECT OF ADMINISTRATION OF A 50MG
AND
100MG PER DAY ORAL CBD PRODUCT, VERSUS A PLACEBO, OVER AN 8-WEEK
PERIOD

Source ( https://bit.ly/3Ax7u3J)
Further company coverage:  BDA.AX 

 ((Reuters.Briefs@thomsonreuters.com;))